Opinion|Videos|October 9, 2024
Impact of Friedreich Ataxia on Quality of Life
Author(s)Sub Subramony, M.D.
Sub Subramony, M.D., discusses how the progression of patients' conditions often leads to a decline in quality of life and functional capabilities, highlighting key clinical indicators that necessitate the adoption of mobility aids.
Advertisement
Episodes in this series
Video content above is prompted by the following:
Can you shed light on the trajectory of patients’ quality of life, functional capabilities, and overall well-being as the condition advances, and how do you typically discern indications in clinical settings that signal a decline in ambulation necessitating the adoption of mobility aids?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
2
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
3
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
4
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
5